EGFR and colorectal cancer: The analysis of the molecular docking results shows thatthe inhibition of the activity of the FGFR1, VEGFR2, EGFR, and HSP90proteins is probably not the reason for their observed selective cytotoxicactivity on glioblastoma and colorectal cancer.